Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 203


BRCA1 and BRCA2 unclassified variants and missense polymorphisms in Algerian breast/ovarian cancer families.

Cherbal F, Salhi N, Bakour R, Adane S, Boualga K, Maillet P.

Dis Markers. 2012;32(6):343-53. doi: 10.3233/DMA-2012-0893.


Physico-chemical control over the single- or double-wall structure of aluminogermanate imogolite-like nanotubes.

Thill A, Maillet P, Guiose B, Spalla O, Belloni L, Chaurand P, Auffan M, Olivi L, Rose J.

J Am Chem Soc. 2012 Feb 29;134(8):3780-6. doi: 10.1021/ja209756j. Epub 2012 Feb 13.


Synthesis of Ge-imogolite: influence of the hydrolysis ratio on the structure of the nanotubes.

Levard C, Masion A, Rose J, Doelsch E, Borschneck D, Olivi L, Chaurand P, Dominici C, Ziarelli F, Thill A, Maillet P, Bottero JY.

Phys Chem Chem Phys. 2011 Aug 28;13(32):14516-22. doi: 10.1039/c1cp20346k. Epub 2011 Jul 12.


Anatomical and technical factors associated with stroke or death during carotid angioplasty and stenting: results from the endarterectomy versus angioplasty in patients with symptomatic severe carotid stenosis (EVA-3S) trial and systematic review.

Naggara O, Touzé E, Beyssen B, Trinquart L, Chatellier G, Meder JF, Mas JL; EVA-3S Investigators.

Stroke. 2011 Feb;42(2):380-8. doi: 10.1161/STROKEAHA.110.588772. Epub 2010 Dec 23. Review.


Growth kinetic of single and double-walled aluminogermanate imogolite-like nanotubes: an experimental and modeling approach.

Maillet P, Levard C, Spalla O, Masion A, Rose J, Thill A.

Phys Chem Chem Phys. 2011 Feb 21;13(7):2682-9. doi: 10.1039/c0cp01851a. Epub 2010 Dec 9.


BRCA1 and BRCA2 germline mutations screening in Algerian breast/ovarian cancer families.

Cherbal F, Bakour R, Adane S, Boualga K, Benais-Pont G, Maillet P.

Dis Markers. 2010;28(6):377-84. doi: 10.3233/DMA-2010-0718.


International distribution and age estimation of the Portuguese BRCA2 c.156_157insAlu founder mutation.

Peixoto A, Santos C, Pinheiro M, Pinto P, Soares MJ, Rocha P, Gusmão L, Amorim A, van der Hout A, Gerdes AM, Thomassen M, Kruse TA, Cruger D, Sunde L, Bignon YJ, Uhrhammer N, Cornil L, Rouleau E, Lidereau R, Yannoukakos D, Pertesi M, Narod S, Royer R, Costa MM, Lazaro C, Feliubadaló L, Graña B, Blanco I, de la Hoya M, Caldés T, Maillet P, Benais-Pont G, Pardo B, Laitman Y, Friedman E, Velasco EA, Durán M, Miramar MD, Valle AR, Calvo MT, Vega A, Blanco A, Diez O, Gutiérrez-Enríquez S, Balmaña J, Ramon y Cajal T, Alonso C, Baiget M, Foulkes W, Tischkowitz M, Kyle R, Sabbaghian N, Ashton-Prolla P, Ewald IP, Rajkumar T, Mota-Vieira L, Giannini G, Gulino A, Achatz MI, Carraro DM, de Paillerets BB, Remenieras A, Benson C, Casadei S, King MC, Teugels E, Teixeira MR.

Breast Cancer Res Treat. 2011 Jun;127(3):671-9. doi: 10.1007/s10549-010-1036-3. Epub 2010 Jul 22.


Evidence of double-walled Al-Ge imogolite-like nanotubes. a cryo-TEM and SAXS investigation.

Maillet P, Levard C, Larquet E, Mariet C, Spalla O, Menguy N, Masion A, Doelsch E, Rose J, Thill A.

J Am Chem Soc. 2010 Feb 3;132(4):1208-9. doi: 10.1021/ja908707a.


Endarterectomy Versus Angioplasty in Patients with Symptomatic Severe Carotid Stenosis (EVA-3S) trial: results up to 4 years from a randomised, multicentre trial.

Mas JL, Trinquart L, Leys D, Albucher JF, Rousseau H, Viguier A, Bossavy JP, Denis B, Piquet P, Garnier P, Viader F, Touzé E, Julia P, Giroud M, Krause D, Hosseini H, Becquemin JP, Hinzelin G, Houdart E, Hénon H, Neau JP, Bracard S, Onnient Y, Padovani R, Chatellier G; EVA-3S investigators.

Lancet Neurol. 2008 Oct;7(10):885-92. doi: 10.1016/S1474-4422(08)70195-9. Epub 2008 Sep 5.


Analysis of the genes coding for the BRCA1-interacting proteins, RAP80 and Abraxas (CCDC98), in high-risk, non-BRCA1/2, multiethnic breast cancer cases.

Novak DJ, Sabbaghian N, Maillet P, Chappuis PO, Foulkes WD, Tischkowitz M.

Breast Cancer Res Treat. 2009 Sep;117(2):453-9. doi: 10.1007/s10549-008-0134-y. Epub 2008 Aug 10.


Detection of ATM gene deletion/duplication by multiplex ligation-dependant probe amplification in childhood lymphoid malignancies: a report from the Children's Oncology Group.

Gumy-Pause F, Ozsahin H, Khoshbeen-Boudal M, Betts DR, Maillet P, Sappino AP.

Leuk Res. 2008 Aug;32(8):1207-13. doi: 10.1016/j.leukres.2007.12.012. Epub 2008 Feb 7.


The contribution of germline rearrangements to the spectrum of BRCA2 mutations.

Casilli F, Tournier I, Sinilnikova OM, Coulet F, Soubrier F, Houdayer C, Hardouin A, Berthet P, Sobol H, Bourdon V, Muller D, Fricker JP, Capoulade-Metay C, Chompret A, Nogues C, Mazoyer S, Chappuis P, Maillet P, Philippe C, Lortholary A, Gesta P, Bézieau S, Toulas C, Gladieff L, Maugard CM, Provencher DM, Dugast C, Delvincourt C, Nguyen TD, Faivre L, Bonadona V, Frébourg T, Lidereau R, Stoppa-Lyonnet D, Tosi M.

J Med Genet. 2006 Sep;43(9):e49.


Twenty-three novel BRCA1 and BRCA2 sequence variations identified in a cohort of Swiss breast and ovarian cancer families.

Maillet P, Chappuis PO, Khoshbeen-Boudal M, Sciretta V, Sappino AP; SIAK Network for Cancer Predisposition Testing and Counseling.

Cancer Genet Cytogenet. 2006 Aug;169(1):62-8.


ATM alterations in childhood non-Hodgkin lymphoma.

Gumy-Pause F, Wacker P, Maillet P, Betts DR, Sappino AP.

Cancer Genet Cytogenet. 2006 Apr 15;166(2):101-11.


A role for atm in E-cadherin-mediated contact inhibition in epithelial cells.

Vutskits GV, Salmon P, Mayor L, Vutskits L, Cudré-Mauroux C, Soriano J, Montesano R, Maillet P, Sappino AP.

Breast Cancer Res Treat. 2006 Sep;99(2):143-53. Epub 2006 Mar 16.


ATM variants and predisposition to childhood T-lineage acute lymphoblastic leukaemia.

Gumy-Pause F, Wacker P, Maillet P, Betts DR, Sappino AP.

Leukemia. 2006 Mar;20(3):526-7; author reply 527. No abstract available.


Prevalence of MYH germline mutations in Swiss APC mutation-negative polyposis patients.

Russell AM, Zhang J, Luz J, Hutter P, Chappuis PO, Berthod CR, Maillet P, Mueller H, Heinimann K.

Int J Cancer. 2006 Apr 15;118(8):1937-40.


ATM promoter analysis in childhood lymphoid malignancies: a brief communication.

Gumy-Pause F, Wacker P, Maillet P, Betts DR, Sappino AP.

Leuk Res. 2006 Mar;30(3):335-7. Epub 2005 Aug 25.


Protein 4.1R expression in normal and dystrophic skeletal muscle.

Delhommeau F, Dalla Venezia N, Morinière M, Collin H, Maillet P, Guerfali I, Leclerc P, Fardeau M, Delaunay J, Baklouti F.

C R Biol. 2005 Jan;328(1):43-56.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk